These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 23948902)

  • 1. Dysregulated mTOR-dependent signaling in neurodegeneration or carcinogenesis: implication for Alzheimer's disease and brain tumors.
    Wang S; Wu J; Nie SD; Bereczki E; Pei JJ
    J Alzheimers Dis; 2013; 37(3):495-505. PubMed ID: 23948902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. mTOR: at the crossroads of aging, chaperones, and Alzheimer's disease.
    Gouras GK
    J Neurochem; 2013 Mar; 124(6):747-8. PubMed ID: 23278352
    [No Abstract]   [Full Text] [Related]  

  • 3. PI3-kinase/Akt/mTOR signaling: impaired on/off switches in aging, cognitive decline and Alzheimer's disease.
    O' Neill C
    Exp Gerontol; 2013 Jul; 48(7):647-53. PubMed ID: 23470275
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Two sides of the same coin: Wnt signaling in neurodegeneration and neuro-oncology.
    Caricasole A; Bakker A; Copani A; Nicoletti F; Gaviraghi G; Terstappen GC
    Biosci Rep; 2005; 25(5-6):309-27. PubMed ID: 16307379
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Roles of Mammalian Target of Rapamycin Signaling and Autophagy Pathway in Alzheimer's Disease].
    Chang YF; Hu WM
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2019 Apr; 41(2):248-255. PubMed ID: 31060682
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Genetically reducing mTOR signaling rescues central insulin dysregulation in a mouse model of Alzheimer's disease.
    Caccamo A; Belfiore R; Oddo S
    Neurobiol Aging; 2018 Aug; 68():1. PubMed ID: 29729422
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Regulation of autophagy by mTOR-dependent and mTOR-independent pathways: autophagy dysfunction in neurodegenerative diseases and therapeutic application of autophagy enhancers.
    Sarkar S
    Biochem Soc Trans; 2013 Oct; 41(5):1103-30. PubMed ID: 24059496
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mammalian target of rapamycin: a valid therapeutic target through the autophagy pathway for Alzheimer's disease?
    Cai Z; Zhao B; Li K; Zhang L; Li C; Quazi SH; Tan Y
    J Neurosci Res; 2012 Jun; 90(6):1105-18. PubMed ID: 22344941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Sirt1 overexpression in neurons promotes neurite outgrowth and cell survival through inhibition of the mTOR signaling.
    Guo W; Qian L; Zhang J; Zhang W; Morrison A; Hayes P; Wilson S; Chen T; Zhao J
    J Neurosci Res; 2011 Nov; 89(11):1723-36. PubMed ID: 21826702
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Triangle of Death in Alzheimer's Disease Brain: The Aberrant Cross-Talk Among Energy Metabolism, Mammalian Target of Rapamycin Signaling, and Protein Homeostasis Revealed by Redox Proteomics.
    Di Domenico F; Barone E; Perluigi M; Butterfield DA
    Antioxid Redox Signal; 2017 Mar; 26(8):364-387. PubMed ID: 27626216
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammalian/mechanistic target of rapamycin (mTOR) complexes in neurodegeneration.
    Querfurth H; Lee HK
    Mol Neurodegener; 2021 Jul; 16(1):44. PubMed ID: 34215308
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Targeting the mTOR signaling network for Alzheimer's disease therapy.
    Wang C; Yu JT; Miao D; Wu ZC; Tan MS; Tan L
    Mol Neurobiol; 2014 Feb; 49(1):120-35. PubMed ID: 23853042
    [TBL] [Abstract][Full Text] [Related]  

  • 13. mTOR signaling in osteosarcoma: Oncogenesis and therapeutic aspects (Review).
    Hu K; Dai HB; Qiu ZL
    Oncol Rep; 2016 Sep; 36(3):1219-25. PubMed ID: 27430283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vascular mTOR-dependent mechanisms linking the control of aging to Alzheimer's disease.
    Galvan V; Hart MJ
    Biochim Biophys Acta; 2016 May; 1862(5):992-1007. PubMed ID: 26639036
    [TBL] [Abstract][Full Text] [Related]  

  • 15. mTOR-dependent signalling in Alzheimer's disease.
    Pei JJ; Hugon J
    J Cell Mol Med; 2008 Dec; 12(6B):2525-32. PubMed ID: 19210753
    [TBL] [Abstract][Full Text] [Related]  

  • 16. mTOR signaling in aging and neurodegeneration: At the crossroad between metabolism dysfunction and impairment of autophagy.
    Perluigi M; Di Domenico F; Butterfield DA
    Neurobiol Dis; 2015 Dec; 84():39-49. PubMed ID: 25796566
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Novel FGFR2-INA fusion identified in two low-grade mixed neuronal-glial tumors drives oncogenesis via MAPK and PI3K/mTOR pathway activation.
    Jain P; Surrey LF; Straka J; Luo M; Lin F; Harding B; Resnick AC; Storm PB; Buccoliero AM; Santi M; Li MM; Waanders AJ
    Acta Neuropathol; 2018 Jul; 136(1):167-169. PubMed ID: 29767381
    [No Abstract]   [Full Text] [Related]  

  • 18. The Molecular Mechanism of Glucagon-Like Peptide-1 Therapy in Alzheimer's Disease, Based on a Mechanistic Target of Rapamycin Pathway.
    Li L
    CNS Drugs; 2017 Jul; 31(7):535-549. PubMed ID: 28540646
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of the mTOR signaling pathway in epilepsy.
    Meng XF; Yu JT; Song JH; Chi S; Tan L
    J Neurol Sci; 2013 Sep; 332(1-2):4-15. PubMed ID: 23773767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of TSC-mTOR signaling on immune cells in immunity and autoimmunity.
    Yang H; Wang X; Zhang Y; Liu H; Liao J; Shao K; Chu Y; Liu G
    J Cell Physiol; 2014 Jan; 229(1):17-26. PubMed ID: 23804073
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.